CCL2 and neoplasm: Several tumor-secreted molecules inhibit DC functions in cancer, including VEGF, TGF-β, GCSF, CCL2, Wnt1a/5a/16b, and IL-6 (272), and oncogenic miRNA networks in tumor cells alter the expression of these genes.